Low-dose S-ketamine in Women With Prenatal Depression
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
Prenatal depression is an important risk factor of postpartum depression. Low-dose ketamine
has been used for depression treatment. As a stereoisomer of ketamine, s-ketamine has similar
effects to ketamine in anti-depression. We speculate that, for pregnant women with prenatal
depression, low-dose s-ketamine infusion after childbirth may reduce the incidence of
postpartum depression.
Phase:
N/A
Details
Lead Sponsor:
Peking University First Hospital
Collaborators:
Beijing Tiantan Hospital Huaian Maternal and Child Health Care Hospital Hunan Provincial Maternal and Child Health Care Hospital Nanjing Maternal and Child Health Care Hospital Peking University International Hospital